0000000000490582

AUTHOR

Kelly L. Close

showing 2 related works from this author

PsychDT Working Group

2015

Background: Diabetes technology is a cornerstone of diabetes management in the 21st century, with advances in available devices over recent years playing a central role in the way that health care has progressed. Psychosocial interventions have been shown to have a positive impact on glycemic control, reduce psychological distress and reduce costs of health care. Addressing and improving psychosocial outcomes that complement biomedical improvements and looking to the future are crucial to enhance patient acceptance of artificial pancreas (AP) systems. Methods: To achieve closer collaboration and comparability across different AP research trials, a working group was established. Results: Exi…

Blood GlucosePancreas ArtificialGerontologyParisEndocrinology Diabetes and MetabolismDecision MakingBiomedical EngineeringBioengineeringArtificial pancreasAutomationQuality of life (healthcare)Diabetes managementDiabetes mellitusHealth careInternal MedicineHumansPsychologyMedicineInterdisciplinary communicationClinical Trials as Topicbusiness.industryManagement scienceProceedings of Meetings/ConferencesCornerstoneCongresses as Topicmedicine.diseaseDiabetes Mellitus Type 1Quality of LifeInterdisciplinary CommunicationbusinessPsychosocialJournal of Diabetes Science and Technology
researchProduct

Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: the SAGE study

2021

International audience; Aims: This secondary analysis of the SAGE study aimed to evaluate the association between glycaemic control and patient-reported outcomes (PROs), in adults with type 1 diabetes (T1DM) across different age groups and regions.Materials and methods: SAGE was a multinational, cross-sectional, observational study in adults with T1DM. Data were collected at a single visit, analysed according to predefined age groups (26-44, 45-64, and ≥65 years), and reported across different regions. PRO questionnaires were applied to assess hypoglycaemia fear (Hypoglycemia Fear Survey-II [HFS-II]), diabetes-related distress (Problem Areas In Diabetes [PAID]), insulin treatment satisfacti…

Adulttype 1 diabetesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentmedia_common.quotation_subject[SDV]Life Sciences [q-bio]030209 endocrinology & metabolism030204 cardiovascular system & hematologyHypoglycemia03 medical and health sciences0302 clinical medicineEndocrinologyQuality of life (healthcare)Diabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinPatient Reported Outcome Measuresmedia_commonAged[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismGlycated HemoglobinType 1 diabetes[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryInsulin[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMiddle Agedmedicine.disease3. Good health[SDV] Life Sciences [q-bio]DistressCross-Sectional StudiesDiabetes Mellitus Type 1glycaemic controlQuality of LifeObservational studyobservational studyWorrybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyClinical psychologyhypoglycaemia
researchProduct